H ospitalized patients with chronic liver disease (CLD) can rapidly deteriorate, particularly when acute decompensation is accompanied by extrahepatic organ dysfunction, a situation associated with high mortality. 1 Early recognition of clinical deterioration is vital if effective, goal-directed therapies are to be used before complications develop.
Clinical early warning scores (EWS) can identify patients at high risk of mortality 3 and are deployed in many hospitals in the United States and Europe. 4 Many different EWS are available (Supplementary Table 1) , and to reduce variation in the United Kingdom, a National EWS (NEWS) was launched by the Royal College of Physicians for use in all adults except pregnant women (Supplementary Table 2) . 5 NEWS allocates weighted points, based on derangement of vital signs from defined normal ranges. The sum of allocated points directs changes in the level of care (eg, more frequent monitoring, involvement of senior staff, calling a rapid response team).
NEWS is calculated by using the following: pulse; respiratory rate; systolic blood pressure; the alert, verbal, painful, unresponsive scale; temperature; peripheral oxygen saturations; and use of supplemental oxygen. NEWS was validated in 35,585 unselected medical patients, achieving an area under the receiver operating characteristic (AUROC) curve of 0.894 (95% CI, 0.887-0.902), 0.857 (95% CI, 0.847-0.868), and 0.722 (95% CI, 0.685-0.759) for discriminating risk of death, unanticipated intensive care unit (ICU) admission, and cardiac arrest, within 24 hours, respectively. 6 The introduction of NEWS was timely, coinciding with a National Confidential Enquiry into Patient Outcome and Death report on treating patients with alcohol-related liver disease (ARLD) in UK hospitals, which identified widespread deficiencies in management. 7 These included poor recognition of deterioration and failure to escalate care. Opportunities were missed to manage sepsis, hypovolemia, renal failure, and variceal hemorrhage effectively. Although current predictive models estimate medium-and longterm prognosis in patients with liver disease, none are validated for short-term outcomes in a ward setting. There is an urgent need for tools to identify liver patients at risk of deterioration, which can be deployed outside the ICU.
However, a potential concern is that many patients with liver disease have chronic physiological derangements affecting NEWS parameters. 8 Patients with cirrhosis often have low systemic vascular resistance, hypotension, or resting tachycardia.
9,10
Pyrexial response may be blunted in decompensated cirrhosis and respiratory rate increased in encephalopathy. 2 These changes raise the possibility that NEWS may perform suboptimally in cirrhosis and other hepatic conditions. Indeed, no EWS has been specifically evaluated in liver patients. Therefore, the aims of our study were to determine whether NEWS accurately discriminates the risk of early in-hospital death, cardiac arrest, or ICU admission in hospitalized patients with liver disease and to compare its performance against all other EWS.
Patients and Methods
The Isle of Wight, Portsmouth, and Southeast Hampshire research ethics committees approved our study (ref. 08/02/1394).
Setting
The study was performed in a large acute hospital in Southern England, serving 650,000 people.
Patient Group
We analyzed a database of electronically captured vital signs recorded in real time from completed consecutive admissions (episodes) of patients aged 16 years between January 1, 2010, and October 31, 2014. Electronic NEWS recordings were in hospital-wide use, excluding the emergency department and ICU. Patients discharged before midnight on the day of admission and patients admitted directly to the ICU were excluded.
Identification and Classification of Patients With Liver Disease
Patient admissions were categorized according to International Classification of Diseases, 10th revision (ICD-10), codes for any finished consultant episode (FCE). Data were extracted from the hospital's Patient Administration System. If care was transferred to another consultant or specialty during the same admission, a new FCE and further set of ICD-10 codes were recorded. Groups included the following: (1) patients with a primary diagnosis of liver disease, (2) patients with a nonprimary liver diagnosis (comorbidity), and (3) patients not allocated any liver disease codes (control group). If patients had more than 1 FCE during admission, the final liver primary diagnosis or top-ranking liver secondary diagnosis (if no primary liver code) before discharge was used. Therefore, each admission could belong to only 1 group.
ICD-10 codes were divided into 4 subgroups to examine NEWS performance according to whether liver disease was acute or chronic, alcohol-induced, or associated with portal hypertension (Supplementary Table 3) . Clinical subgroups included the following: (1) acute alcohol-induced liver injury, (2) other acute injury, (3) CLD without cirrhosis, and (4) cirrhosis. Liver-related ICD-10 codes were identified separately using Summary Hospitallevel Mortality Indicator (SHMI) definitions used routinely in the UK's National Health Service.
11 Three previously defined SHMI groups were selected: (1) alcohol-related liver disease (SHMI group 93), (2) other liver disease (SHMI group 94), and (3) hepatitis, viral infection, and other infections (SHMI group 6, Clinical Classification System group 6), which includes viral hepatitis, autoimmune, and drug-induced liver disease (Supplementary  Table 4) .
11 Division between SHMI groups 93 and 94 may be relevant because ethanol can effect cardiovascular physiology independent of liver disease. Patients were defined as having no liver disease if none of their episodes of care during or before this study contained any liver ICD-10 codes (primary or secondary diagnosis) identified by the 3 SHMI groups or the 4 clinical subgroups.
Outcomes
The primary outcome was any of the following events occurring within 24 hours of an observation set: in-hospital mortality, unanticipated ICU admission, or cardiac arrest.
Data Collection
Nurses recorded data required for NEWS at the bedside using electronic devices running VitalPAC (System C, London, UK) software.
12 Vital sign sets with implausible physiological values were excluded, as were events for which no observations were recorded within the preceding 24 hours. Reasons for this included end-of-life care or an outcome after admission to the ICU. We excluded observations recorded after a primary outcome had occurred.
Comparison of National Early Warning Score With Other Early Warning Scores
To compare the performance of NEWS 6 with 34 other published EWS in patients with liver disease, we applied each EWS to our data set.
Statistics
Data manipulation was performed using Microsoft Visual Fox-Pro 9.0 (Microsoft, Redmond, WA). The ability of NEWS to discriminate outcomes was assessed using the AUROC on IBM SPSS version 22 (IBM, Armonk, NY). Data were analyzed regarding the percentage of observations that would trigger medical review if escalation occurred at or above a given NEWS value, and the percentage of observations that were followed by death, cardiac arrest, or ICU admission within 24 hours at or above this value. EWS efficiency curves were constructed using these data. 13 All observation sets were treated independently.
Results

Study Population
Categorizing patient episodes using the 4 clinical subgroups, 773 patients (1197 episodes) were discharged with a primary diagnosis of liver disease and 2525 (3953 episodes) were discharged with a nonprimary (comorbid) diagnosis. In the same period, if patient episodes were categorized using the 3 SHMI groups, 1216 patients (2016 episodes) were discharged with a primary diagnosis of liver disease and 4957 (6459 episodes) were discharged with a nonprimary (comorbid) diagnosis. After excluding episodes with no observations recorded for 24 hours before an adverse event, the final data set in which episodes were categorized using the 4 clinical subgroups comprised 722 patients (1112 episodes) with a primary liver diagnosis, and 2339 patients (3658 episodes) with a nonprimary liver diagnosis (Table 1) . Similarly, after the same exclusions, the final data set in which patient episodes were categorized using the 3 SHMI groups comprised 1136 patients (1894 episodes) with a primary liver diagnosis, and 4486 patients (5840 episodes) with a nonprimary liver diagnosis (Supplementary Table 5) .
From these data sets we examined the performance of NEWS in liver disorders using more than 3.5 million vital sign sets. As described in the Patients and Methods section, we included all observations for analysis. We identified 39,619 sets from patients allocated a liver ICD-10 code as the primary diagnosis and 105,092 from patients with a nonprimary liver diagnosis defined by the 4 clinical subgroups; in addition to 3,525,420 sets from patients never allocated a liver ICD-10 code (control group) ( Table 1 Figure 2B ). Tables 7 and 8 ). Although NEWS also appeared to perform better in all other liver cohorts, there was no significant difference between NEWS and other high-performing scores. NEWS performed better than the 34 EWS for alcohol and non-alcohol-related liver disease groups according to the SHMI classification (Supplementary Table 9 ).
Discussion
In the United Kingdom, the Royal College of Physicians recommended that NEWS is deployed to standardize assessment of acute illness severity in hospitals. Our study was designed to test the hypothesis that NEWS might not accurately predict serious events in patients with liver disease owing to pre-existing altered physiology associated with the underlying condition. This hypothesis was disproven and we were encouraged to find that NEWS remained a highly accurate discriminator of adverse events in liver disorders, with its performance being highest in ARLD. Sensitivity and specificity was reduced slightly in patients with cirrhosis but remained clinically relevant. In a direct comparison with 34 other EWS systems, NEWS was the most discriminating in patients with primary or nonprimary diagnostic codes for liver disease.
As described in the Systemic Inflammation Hypothesis, patients with advanced liver disease are imperiled by progressive interactions between circulatory disturbance and systemic inflammation. 14 These can worsen abruptly, leading to acute-on-chronic liver failure (ACLF), multiple organ dysfunction, and death. 15 To allow effective interventions, physicians need to be promptly alerted to deterioration. Unfortunately, many doctors fail to recognize deteriorating patients with liver disease.
7
In our study, NEWS was validated as an accurate discriminator of short-term (<24 h) deterioration of inpatients with liver disease. The recent increase in hospital admissions secondary to cirrhosis in the United Kingdom 16 and the 43% increase in cirrhosis-associated deaths per year in the United States make these findings pertinent. 17 The reliance of NEWS on routine vital signs facilitates serial monitoring, a potential advantage over many predictive scores. Its widespread adoption provides opportunities for standardization of care and the potential benefits.
The availability of other predictors of short-term mortality for ward-based patients with CLD is limited.
Model for End Stage Liver Disease
18,19 and UK End Stage Liver Disease scores 20 are more accurate in predicting medium-term mortality. Child-Pugh score is limited by 2 subjective parameters and a ceiling effect. 21 These scoring systems, along with the Glasgow alcoholic hepatitis score 22 and Maddrey's discriminant function, 23 are reliant on laboratory parameters and less easily applied at the bedside for frequent monitoring. Clinical, hematologic, and biochemical criteria can predict short-term mortality using the Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II, and Simplified Acute Physiology II scores, but these have been validated only in ICU settings. 24 These prognostic models appear most accurate 48 hours after ICU admission and may not perform optimally on general wards. 25, 26 The adapted Chronic Liver Failure (CLIF)-Sequential Organ Failure Assessment score and CLIF-Consortium Organ Failure score for ACLF were validated as predictors of 28-day transplant-free mortality. 1, 27 Despite outperforming the Model for End Stage Liver Disease and Child-Pugh, the predictive value of the CLIF Consortium Organ Failure score for ACLF is lowest on day 1 of diagnosis and may not reveal the earliest point of deterioration. 27 Thus, none of the existing liver-specific scores have been validated as predictors of short-term (<24 h) mortality in a ward environment.
NEWS incorporates several parameters that can be deranged in the systemic inflammatory response syndrome. This may be relevant to our finding that NEWS performs especially well in ARLD patients, who are particularly susceptible to sepsis. 28 Alcohol misuse can lead to an altered intestinal microbiome, increased translocation of bacteria, and increased endotoxin levels. 29, 30 These events can worsen the liver injury itself, particularly alcoholic hepatitis.
31,32
A recent multicenter study showed strong associations between systemic inflammatory response syndrome, multi-organ failure, and death in patients with alcoholic hepatitis, independent of infection. 33 Furthermore, alcohol-related cirrhosis may be associated with higher portal pressures and a more hyperdynamic circulation. 34, 35 Similarly, low arterial pressures and increased intrahepatic resistance correlate with mortality in alcohol-related ACLF. 36 Although the efficiency of NEWS was slightly reduced in cirrhosis compared with other subgroups, its ability to identify acute deterioration remained high. Importantly, AUROC values for NEWS in this group were higher than other EWS systems.
The strength of this study lies in its access to a large electronic dataset of 4 years of hospital-wide vital signs captured at the point of care. The exclusion rate was small (w6%), reflecting a valid cross-section of inpatients. Potential weaknesses included reliance on ICD-10 coding, which may have limited the accurate placement of patients into clinical subgroups. In addition, this study was not designed to show whether introducing NEWS improved clinical care and saved lives in patients with liver diseases. This would be difficult to show because NEWS is merely a clinical tool to identify patients at risk for deterioration.
NEWS forms only 1 part of the "Chain of Prevention," 37 which requires staff education, timely vital sign monitoring, escalation of care, and appropriate clinical responses. No EWS could be expected to improve outcomes if other components of the chain are not optimized. In addition, metrics that might indicate NEWS-mediated improvements in care (eg, microbiology cultures, fluid resuscitation, ICU outreach referrals) are affected by factors with no bearing on the performance of EWS. Furthermore, some metrics (eg, number of ICU outreach referrals) might be difficult to interpret. For instance, would a reduction in the number of critical care referrals be a good or bad indicator? One could argue that increased referral to the ICU implies a more preemptive approach to critical illness, whereas another might argue that fewer calls result from improved ward care.
Other potential weaknesses of our study include its retrospective nature and the fact that we obtained date/ time of death (or discharge) from the hospital's patient administration computer system. Some events may have been recorded later than they occurred, potentially underestimating the number of observations followed by an event within 24 hours. For simplicity, we used all observations for analysis. It would have been possible to randomly choose one observation per episode, either by randomly choosing one, or to select a random time and take the nearest NEWS value. However, we have shown previously that whichever of these approaches is taken, the ranking of competing EWSs is essentially unchanged. 37 Our analysis aimed to rank the performance of different EWSs and so we used the simplest computationally.
This work could be extended by identifying whether changes in NEWS over time are more accurate predictors of deterioration, particularly in patients judged to be activating NEWS despite appearing clinically stable. It also might be possible to combine bedside observations with laboratory markers to develop a scoring system with additional medium-term predictive qualities.
Many clinicians would agree that shock or severe sepsis are easily recognized, however, many doctors fail to recognize deteriorating patients with liver disease and other conditions. 7,38,39 An assessment using NEWS is easily performed by inexperienced and experienced staff alike. It provides an aggregate score based on the, sometimes subtle, physiologic disturbance of several vital signs and may permit earlier risk stratification than when detailed clinical examination and initial laboratory test results are required. However, this current study was not designed to determine if there was such a measurable benefit from using NEWS.
In conclusion, we have shown that NEWS accurately discriminates risk of death, ICU admission, or cardiac arrest within 24 hours in patients with liver-related diagnoses. Its widespread use in hospitals provides an easy-to-use assessment without needing to modify parameters, weightings, or escalation criteria. This could be particularly valuable for identifying patients with decompensated liver disease at risk of deterioration. Table 2 ) are shown in italics. These ICD-10 diagnoses were excluded because they were not applicable to adults (congenital disease), had a poor specificity for identifying patients with liver disease, or because they denoted relatively benign disease that would be unlikely to influence physiology or lead to admission. A further 6 ICD-10 codes were included in the study's clinical subgroups that do not appear in either SHMI group 93, 94, or 6 (CCS 6). These include hemochromatosis (it was decided that to require hospital admission patients are likely to have a liver complication) and esophageal and gastric varices (it was decided that these complications of portal hypertension are likely to be highly specific for liver disease). CCS, Clinical Classification System. Supplementary Supplementary 
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